Leuprolide Acetate

CAS 74381-53-6 17 FDA-DMF suppliersPeptide

Overview

Leuprolide acetate is a synthetic nonapeptide analogue of gonadotropin-releasing hormone (GnRH) used in the treatment of hormone-responsive cancers such as prostate cancer and conditions like endometriosis. It acts by temporarily suppressing the production of certain hormones.

API suppliers (15)

Suppliers of Leuprolide Acetate backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • CHEMI SPAItaly1 active DMF
  • BACHEM INC1 active DMF
  • CHEMI SPAItaly1 active DMF
  • Takeda Pharmaceutical Company LimitedJapan1 active DMF
  • Piramal Pharma LimitedIndia1 active DMF
  • BACHEM INC1 active DMF
  • CHEMI SPAItaly1 active DMF
  • Piramal Pharma LimitedIndia1 active DMF
  • Takeda Pharmaceutical Company LimitedJapan1 active DMF
  • Piramal Pharma LimitedIndia1 active DMF
  • BACHEM AMERICAS INC
  • SPECGX LLCUnited States
  • Genzyme CorporationUnited States
  • Taro Pharmaceutical Industries Ltd.Israel
  • CHINESE PEPTIDE COChina

Therapeutic areas

OncologyEndocrinologyGynecology

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.